A detailed history of Ashton Thomas Securities, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Ashton Thomas Securities, LLC holds 250 shares of KURA stock, worth $2,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Holding current value
$2,515
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$18.57 - $23.23 $4,642 - $5,807
250 New
250 $4.89 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $673M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Ashton Thomas Securities, LLC Portfolio

Follow Ashton Thomas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Securities, LLC with notifications on news.